发明授权
US07238724B2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
失效
药物组合物作为二肽基肽酶-IV（DPP-IV）的抑制剂
- 专利标题： Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
- 专利标题（中）： 药物组合物作为二肽基肽酶-IV（DPP-IV）的抑制剂
-
申请号： US11036258申请日： 2005-01-13
-
公开(公告)号： US07238724B2公开(公告)日： 2007-07-03
- 发明人: David J. Madar , Stevan W. Djuric , Melissa J. Michmerhuizen , Hana A. Kopecka , Xiaofeng Li , Kenton L. Longenecker , Zhonghua Pei , Daisy Pireh , Hing L. Sham , Kent D. Stewart , Bruce G. Szczepankiewicz , Paul E. Wiedeman , Hong Yong
- 申请人： David J. Madar , Stevan W. Djuric , Melissa J. Michmerhuizen , Hana A. Kopecka , Xiaofeng Li , Kenton L. Longenecker , Zhonghua Pei , Daisy Pireh , Hing L. Sham , Kent D. Stewart , Bruce G. Szczepankiewicz , Paul E. Wiedeman , Hong Yong
- 申请人地址： US IL Abbott Park
- 专利权人： Abbott Laboratories
- 当前专利权人： Abbott Laboratories
- 当前专利权人地址： US IL Abbott Park
- 代理商 Andrew M. Parial; Johanna M. Corbin
- 主分类号： A61K31/40
- IPC分类号： A61K31/40 ; A61K31/401 ; A61K31/454 ; A61K31/4545 ; A61K31/506 ; C07D405/12 ; C07D401/12 ; C07D211/58 ; C07D239/42
摘要：
The present invention relates to compounds that inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases.
公开/授权文献
信息查询
